Karl-Dimiter Bissig
Pediatrics, Medical Genetics
Chen Family Associate Professor of Pediatrics
Research Interests
Our group is interested in diseases of the liver, ranging from viral hepatitis to metabolic liver disorders and liver cancer. The lab specializes in human liver chimeric mice and created the first xenograft model for metabolic liver disease as well as a novel patient derived cancer model. We use these next generation humanized mouse models to develop new therapeutic approaches, such as metabolic pathway reprogramming - a CRISPR based gene therapy approach.
Bio
Our group is interested in diseases of the liver, ranging from viral hepatitis to metabolic liver disorders and liver cancer. The lab specializes in human liver chimeric mice and created the first xenograft model for metabolic liver disease as well as a novel patient derived cancer model. We use these next generation humanized mouse models to develop new therapeutic approaches, such as metabolic pathway reprogramming - a CRISPR based gene therapy approach.
Education
- MD./PhD. Universitat Bern (Switzerland), 2000
- Inselspital (Switzerland), 2005
- Salk Institute for Biological Studies, 2011
Positions
- Chen Family Associate Professor of Pediatrics
- Associate Professor in Pediatrics
- Associate Professor of Biomedical Engineering
- Associate Professor in Pharmacology and Cancer Biology
- Member of the Duke Cancer Institute
- Affiliate of the Duke Regeneration Center
Courses Taught
- BME 791: Graduate Independent Study
- PHARM 394: Research Independent Study
- PHARM 493: Research Independent Study
- PHARM 494: Research Independent Study